FineMark National Bank & Trust’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$14.9M Buy
45,613
+1,323
+3% +$420K 0.47% 57
2025
Q3
$12.5M Sell
44,290
-802
-2% -$233K 0.41% 63
2025
Q2
$12.6M Buy
45,092
+482
+1% +$137K 0.43% 68
2025
Q1
$13.9M Sell
44,610
-172
-0.4% -$50.8K 0.51% 63
2024
Q4
$11.7M Sell
44,782
-334
-0.7% -$99.1K 0.41% 73
2024
Q3
$14.5M Sell
45,116
-928
-2% -$304K 0.51% 60
2024
Q2
$14.4M Buy
46,044
+126
+0.3% +$37K 0.53% 55
2024
Q1
$13.1M Sell
45,918
-381
-0.8% -$111K 0.49% 62
2023
Q4
$13.3M Buy
46,299
+508
+1% +$138K 0.55% 52
2023
Q3
$12.3M Sell
45,791
-1,418
-3% -$354K 0.54% 47
2023
Q2
$10.5M Sell
47,209
-97
-0.2% -$22.5K 0.43% 60
2023
Q1
$11.4M Buy
47,306
+244
+0.5% +$59.9K 0.49% 54
2022
Q4
$12.4M Sell
47,062
-4,206
-8% -$1.13M 0.56% 46
2022
Q3
$11.6M Buy
51,268
+1,057
+2% +$256K 0.55% 42
2022
Q2
$12.2M Buy
50,211
+1,767
+4% +$433K 0.54% 42
2022
Q1
$11.7M Buy
48,444
+11,614
+32% +$2.67M 0.46% 52
2021
Q4
$8.29M Sell
36,830
-2,710
-7% -$572K 0.31% 73
2021
Q3
$8.41M Sell
39,540
-668
-2% -$154K 0.36% 69
2021
Q2
$9.8M Sell
40,208
-447
-1% -$110K 0.4% 61
2021
Q1
$10.1M Sell
40,655
-278
-0.7% -$66.3K 0.43% 54
2020
Q4
$9.41M Sell
40,933
-1,016
-2% -$234K 0.42% 54
2020
Q3
$10.7M Sell
41,949
-726
-2% -$180K 0.52% 45
2020
Q2
$10.1M Buy
42,675
+827
+2% +$189K 0.56% 44
2020
Q1
$8.48M Buy
41,848
+230
+0.6% +$50.2K 0.53% 48
2019
Q4
$10M Buy
41,618
+1,527
+4% +$337K 0.5% 51
2019
Q3
$7.76M Sell
40,091
-958
-2% -$184K 0.41% 63
2019
Q2
$7.57M Buy
41,049
+2,112
+5% +$378K 0.42% 64
2019
Q1
$7.4M Buy
38,937
+1,479
+4% +$282K 0.43% 60
2018
Q4
$7.29M Buy
37,458
+1,480
+4% +$289K 0.49% 51
2018
Q3
$7.46M Buy
35,978
+553
+2% +$109K 0.45% 52
2018
Q2
$6.54M Buy
35,425
+1,243
+4% +$220K 0.4% 60
2018
Q1
$5.83M Buy
34,182
+1,771
+5% +$325K 0.37% 68
2017
Q4
$5.64M Buy
32,411
+1,526
+5% +$270K 0.36% 70
2017
Q3
$5.76M Buy
30,885
+2,122
+7% +$376K 0.38% 69
2017
Q2
$4.95M Buy
28,763
+536
+2% +$87.2K 0.36% 73
2017
Q1
$4.63M Buy
28,227
+4,435
+19% +$737K 0.34% 80
2016
Q4
$3.48M Sell
23,792
-1,160
-5% -$175K 0.28% 90
2016
Q3
$4.16M Buy
24,952
+867
+4% +$147K 0.44% 63
2016
Q2
$3.67M Buy
24,085
+12,255
+104% +$1.91M 0.41% 72
2016
Q1
$1.77M Sell
11,830
-194
-2% -$28.8K 0.21% 106
2015
Q4
$1.95M Sell
12,024
-332
-3% -$52.2K 0.23% 107
2015
Q3
$1.71M Buy
12,356
+1,121
+10% +$177K 0.23% 106
2015
Q2
$1.73M Buy
11,235
+699
+7% +$112K 0.23% 111
2015
Q1
$1.68M Sell
10,536
-227
-2% -$35.8K 0.23% 113
2014
Q4
$1.71M Buy
10,763
+425
+4% +$66.2K 0.25% 111
2014
Q3
$1.45M Buy
10,338
+1,187
+13% +$155K 0.23% 114
2014
Q2
$1.08M Buy
9,151
+279
+3% +$32.3K 0.18% 126
2014
Q1
$1.09M Buy
8,872
+435
+5% +$52.8K 0.2% 118
2013
Q4
$963K Buy
8,437
+76
+0.9% +$8.64K 0.2% 128
2013
Q3
$936K Buy
8,361
+1,162
+16% +$126K 0.23% 112
2013
Q2
$711K Buy
+7,199
New +$747K 0.21% 98

Other funds holding AMGN

FineMark National Bank & Trust's AMGN Position: Q4 2025 in Review

FineMark National Bank & Trust increased its Amgen (AMGN) stake by 3% in Q4 2025, buying an estimated $420K and bringing the position to 45,613 shares worth $14.9M. The position accounts for 0.47% of the portfolio, ranked #57.

FineMark National Bank & Trust first reported a position in AMGN in Q2 2013 and has held it in 51 quarters since. 3,084 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • FineMark National Bank & Trust held 45,613 shares of Amgen worth $14.9M as of Q4 2025.
  • FineMark National Bank & Trust bought 1,323 Amgen shares in Q4 2025, an estimated $420K.
  • Amgen made up 0.47% of FineMark National Bank & Trust's portfolio in Q4 2025, its #57 holding.
  • FineMark National Bank & Trust first reported a position in Amgen in Q2 2013 and has held it in 51 quarters since.
  • 3,084 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on FineMark National Bank & Trust's 13F filing for Q4 2025, filed 12 Feb 2026.